NCT06050447 Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
| NCT ID | NCT06050447 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Immanuel Kant Baltic Federal University |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2024-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2023-09-01 with a primary completion date of 2024-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.
Eligibility Criteria
Inclusion Criteria: * Histologically proven primary adenocarcinoma of bowel; * All patients who have indications for surgical treatment of colorectal cancer based on the decision of the oncological council; * Signed informed consent with agreement to attend all study visits; Exclusion Criteria: * Unresectable tumor or contradictions to surgery; * Indications for chemotherapy or radiation therapy prior to surgery; * Patient withdrawal from the trial or loss of follow-up; * Emergent operation; * Pregnancy.
Contact & Investigator
Mikhail A Agapov, PhD
PRINCIPAL INVESTIGATOR
Baltic Federal University
Frequently Asked Questions
Who can join the NCT06050447 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06050447 currently recruiting?
Yes, NCT06050447 is actively recruiting participants. Contact the research team at tatianagarmanova@gmail.com for enrollment information.
Where is the NCT06050447 trial being conducted?
This trial is being conducted at Kaliningrad, Russia.
Who is sponsoring the NCT06050447 clinical trial?
NCT06050447 is sponsored by Immanuel Kant Baltic Federal University. The principal investigator is Mikhail A Agapov, PhD at Baltic Federal University. The trial plans to enroll 1,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.